NCT04981444

Brief Summary

Open-label, single-arm, prospective study. Subjects will undergo one session of 2D Transthoracic Echocardiogram (2D-TTE) ultrasound. The ultrasound will be performed by a trained sonographer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 4, 2021

Completed
18 days until next milestone

Study Start

First participant enrolled

July 22, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 29, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 23, 2022

Completed
Last Updated

November 14, 2022

Status Verified

July 1, 2022

Enrollment Period

2 months

First QC Date

July 4, 2021

Last Update Submit

November 10, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • ACCURACY- Optimization of an automated ultrasound cardiac guidance tool.

    To acquire images from different transducer positions, trajectories, and views, at different acoustic windows for capturing images and location relative to body and probe. This study is designed to capture data for the training of the UltraSight Guidance software AI models. The obtained data will not be anlyzed for statistical purposes but will only be used for the algorithm development based on the technician movements recording, with no reference to images quality or medical utilization.

    1 year

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Up to 75 cardiac patients will be enrolled in this study.

You may qualify if:

  • Age 18 years and above.
  • Patients able to understand, read and sign the informed consent
  • Patient willing to answer a short questionnaire

You may not qualify if:

  • Not willing or not able to sign an inform consent
  • Physical limitation to maneuvering the probe on the body
  • Unable to lie flat for study
  • Patients experiencing a known or suspected acute cardiac event
  • Patients with severe chest wall abnormalities
  • Patients who have undergone pneumonectomy
  • Patients whose anatomy does not lend itself to echocardiography

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States

Location

Study Officials

  • Praveen Mehrotra, MD

    Thomas Jefferson University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2021

First Posted

July 29, 2021

Study Start

July 22, 2021

Primary Completion

September 20, 2021

Study Completion

September 23, 2022

Last Updated

November 14, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations